Carotid artery stenting according to the "tailored CAS" algorithm performed in the very elderly patients: The thirty day outcome

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 5, 2013, Pages 681-688

  Dzierwa, Karolina ^a   Pieniazek, Piotr ^a   Tekieli, Lukasz ^a   Musialek, Piotr ^a   Przewlocki, Tadeusz ^a   Kablak Ziembicka, Anna ^a   Kosobucka Peszat, Renata ^b   Machnik, Roman ^a   Trystula, Mariusz ^b   Podolec, Piotr ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

carotid stenosis; cerebrovascular disease; stroke

Indexed keywords

ADULT; AGE; AGED; ALGORITHM; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR THERAPEUTIC DEVICE; CAROTID ARTERY STENT; CAROTID ARTERY STENTING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPROTECTION SYSTEM DEVICE; REVIEW; RISK FACTOR; SAFETY; SUDDEN DEATH; TRANSIENT ISCHEMIC ATTACK;

CAROTID STENOSIS; CEREBROVASCULAR DISEASE; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; ANGIOPLASTY, BALLOON; ASYMPTOMATIC DISEASES; CAROTID STENOSIS; COMORBIDITY; DECISION SUPPORT TECHNIQUES; FEMALE; HOSPITALS, HIGH-VOLUME; HUMANS; MALE; PATIENT SELECTION; POLAND; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886947403     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25025     Document Type: Review

References (32)

1. Gurm HS, Nallamothu BK, Yadav J,. Safety of carotid artery stenting for symptomatic carotid artery disease: A meta-analysis. Eur Heart J 2008; 29: 113-119.
2. Mantese VA, Timaran CH, Chiu D, Begg RJ, Brott TG,. CREST Investigators. The carotid revascularization endarterectomy versus stenting trial (CREST) stenting versus carotid endarterectomy for carotid disease. Stroke 2010; 41: S31-S34
3. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ, Jacobs AK, Smith SC Jr,. Guideline on the management of patients with extracranial carotid and vertebral artery disease: Executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke 2011; 42: e420-e463.
4. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K,; Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-Artery stenting versus endartectomy in high-risk patients. N. Engl. J. Med. 2004; 351: 1493-1501.
5. International Carotid Stenting Study Investigators, Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, Lo TH, Gaines P, Dorman PJ, Macdonald S, Lyrer PA, Hendriks JM, McCollum C, Nederkoorn PJ, Brown MM,. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): An interim analysis of a randomised controlled trial. Lancet 2010; 375: 985-997.
6. Myla S, Bacharach JM, Ansel GM, Dippel EJ, McCormick DJ, Popma JJ,. Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: The EPIC trial results. Catheter Cardiovasc. Interv. 2010; 75: 817-822.
7. Clair DG, Hopkins LN, Mehta M, Kasirajan K, Schermerhorn M, Schönholz C, Kwolek CJ, Eskandari MK, Powell RJ, Ansel GM,; EMPiRE Clinical Study Investigators. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc. Interv. 2011; 77: 420-429.
8. Matsumura JS, Gray W, Chaturvedi S, Gao X, Cheng J, Verta P,; CAPTURE 2 Investigators and Executive Committee. CAPTURE 2 risk-adjusted stroke outcome benchmarks for carotid artery stenting with distal embolic protection. J. Vasc. Surg. 2010; 52: 576-583, 583.e1-583.e2.
9. Ansel GM, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinert D, Myla S, Das T, Cremonesi A,; Investigators for the ARMOUR Pivotal Trial. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial. Catheter Cardiovasc. Interv. 2010; 76: 1-8.
10. Hobson RW 2nd, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ, Graham DL, Howard G,. CREST Investigators Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J. Vasc. Surg. 2004; 40: 1106-1111.
11. Grant A, White C, Ansel G, Bacharach M, Metzger C, Velez C,. Safety and efficacy of carotid stenting in the very elderly. Catheter Cardiovasc. Interv. 2010; 75: 651-655.
12. Chaturvedi S, Matsumura JS, Gray W, Xu C, Verta P,. CAPTURE 2 Investigators and Executive Committee Carotid artery stenting in octogenarians: Periprocedural stroke risk predictor analysis from the multicenter carotid ACCULINK/ACCUNET post approval trial to uncover rare events (CAPTURE 2) clinical trial. Stroke 2010; 41: 757-764.
13. Micari A, Stabile E, Cremonesi A, Vadalà G, Castriota F, Pernice V, Sorropago G, Rubino P, Biamino G,. Carotid artery stenting in octogenarians using a proximal endovascular occlusion cerebral protection device: A Multicenter Registry. Catheter. Cardiovasc. Interv. 2010; 76: 9-15.
14. Pienia̧zek P, Musiałek P, Kabłak-Ziembicka A, Tekieli L, Motyl R, Przewlocki T, Moczulski Z, Pasowicz M, Sokolowski A, Lesniak-Sobelga A, Zmudka K, Tracz W,. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: Early and 5-Year Results From a Prospective Academic Registry of 535 Consecutive Procedures (TARGET-CAS). JEVT 2008; 15: 249-262.
15. Pienia̧zek P, Tekieli L, Musiałek P, Kabłak Ziembicka A, Przewłocki T, Motyl R, Dzierwa K, Paluszek P, Hlawaty M, Zmudka K, Podolec P,. Carotid artery stenting according to the tailored-CAS algorithm is associated with a low complication rate at 30 days: Data from the TARGET-CAS study. Kardiol. Pol. 2012; 70: 378-386.
16. Setacci C, de Donato G, Chisci E, Setacci F, Pieraccini M, Cappelli A, Palasciano G, Castriota F, Cremonesi A,. Is carotid artery stenting in octogenarians really dangerous? JEVT 2006; 13: 302-309.
17. Cremonesi A, Gieowarsingh S, Spagnolo B, Manetti R, Liso A, Furgieri A, Barattoni MC, Ghetti L, Tavazzi L, Castriota F,. Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: The tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry). EuroIntervention 2009; 5: 589-598.
18. Chiam PT, Roubin GS, Panagopoulos G, Iyer SS, Green RM, Brennan C, Vitek JJ,. One-year clinical outcomes, midterm survival, and predictors of mortality after carotid stenting in elderly patients. Circulation 2009; 119: 2343-2348.
19. Henry M, Henry I, Polydorou A, Hugel M,. Carotid angioplasty and stenting in octogenarians: Is it safe? Catheter. Cardiovasc. Interv. 2008; 72: 309-317.
20. Chaer RA, Shen J, Rao A, Cho JS, Abu Hamad G, Makaroun MS,. Cerebral reserve is decreased in elderly patients with carotid stenosis. J. Vasc. Surg. 2010; 52: 569-574
21. Tekieli L, Pieniazek P, Musialek P, Kablak-Ziembicka A, Przewlocki T, Trystula M, Moczulski Z, Dzierwa K, Paluszek P, Podolec P,. Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population. J. Endovasc. Ther. 2012; 19: 316-324.
22. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES,. Variation in carotid endarterectomy mortality in the medicare population. JAMA 1998; 279; 1278-1281.
23. Miller MT, Comerota AJ, Tzilinis A, Daoud Y, Hammerling J,. Carotid endarterectomy in octogenarians: Does increased age indicate 'high risk'? J. Vasc. Surg. 2005; 41: 231-237.
24. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, Hennerici M, Stingele R, Fiehler J, Zeumer H, Jansen O,. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: A multinational, prospective, randomised trial. Lancet Neurol. 2008; 7: 893-902.
25. Alamowitch S, Eliasziw M, Algra A, Meldrum H, Barnett HJ,. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 2001; 357: 1154-1160.
26. Kablak-Ziembicka A, Przewlocki T, Pieniazek P, Musialek P, Tekieli L, Rosławiecka A, Motyl R, Zmudka K, Tracz W, Podolec P,. Predictors of cerebral reperfusion injury after carotid stenting: The role of transcranial color-coded Doppler ultrasonography. J. Endovasc. Ther. 2010; 17: 556-563.
27. van Lammeren GW, Reichmann BL, Moll FL, Bots ML, de Kleijn DP, de Vries JP, Pasterkamp G, de Borst GJ,. Atherosclerotic plaque vulnerability as an explanation for increased risk of stroke in elderly undergoing carotid artery stenting. Stroke 2011; 42: 2550-2555.
28. Goldstein LB, McCrory DC, Landsman PB, Samsa GP, Ancukiewicz M, Oddone EZ, Matchar DB,. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke 1994; 25: 1116-1121.
29. Velez CA, White CJ, Reilly JP, Jenkins JS, Collins TJ, Grise MA, McMullan PW, Ramee SR,. Carotid artery stent placement is safe in the very elderly (≥80 years). Catheter. Cardiovasc. Interv. 2008; 72: 303-308.
30. Hofman R, Kypta A, Steinweider C, et al. Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary disease. Heart 2005; 91: 1438-1441.
31. Pieniazek P, Kabłak-Ziembicka A, Pasowicz M, Przewłocki T, Zmudka K, Moczulski Z, Tracz W,. Reversed blood flow during internal carotid artery stenting using Parodi Anti-Emboli System - progress in protection against cerebral stroke. Kardiol. Pol. 2002; 57: 322-3230; discussion 331.
32. Pieniazek P, Musialek P, Dzierwa K, Motyl R, Trystuła M, Przewlocki T, Kabłak-Ziembicka A, Tekieli L, Paluszek P, Moczulski Z, Sadowski J, Tracz W,. Flow reversal for proximal neuroprotection during endovascular management of critical symptomatic carotid artery stenosis coexisting with ipsilateral external carotid artery occlusion. J. Endovasc. Ther. 2009; 16: 744-751.